A Study to Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years

Summary

The objective of this study is to evaluate the effectiveness of SCTV01E in participants aged ≥18 years.

Timeline

Start

2022-12-26

Primary completion

2023-05-10

Completion

2024-04

Publications

• Yan L, Yi J, Liu D, Li J, Baidoo AAH, Xie L. Baseline Anti-SARS-CoV-2 IgG and Protection from Symptomatic Infection: Post Hoc Analysis of the SCTV01E Phase 3 Randomized Trial. Vaccines (Basel). 2025 Sep 19;13(9):984. doi: 10.3390/vaccines13090984.

Drugs

Indications